The Genome Engineering for Regenerative Medicine (GERM) Consortium
Grant Project Details:
Awardee:
David Largaespada, PhD
Location:
University of Minnesota | Minneapolis, MN
Explore all RMM grants awarded since inception
Grant Description
Addressing the critical need for quality and safety standards in gene-edited therapies, this new consortium will bring together academic and industry experts to establish best practices for gene delivery, editing and evaluation. The GERM Consortium will provide essential guidance and resources to ensure that genetically engineered therapies are developed with precision and safety. Through this collaborative effort, Minnesota will become a hub for innovation and regulatory compliance in cell and gene therapy.